S1000A12, Chitotriosidase, and Resolvin D1 as Potential Biomarkers of Familial Mediterranean Fever.
10.3346/jkms.2015.30.9.1241
- Author:
Ali TAYLAN
1
;
Oguz GURLER
;
Burak TOPRAK
;
Ali Riza SISMAN
;
Hulya YALCIN
;
Ayfer COLAK
;
Ismail SARI
Author Information
1. Izmir Tepecik Training and Research Hospital, Department of Rheumatology, Izmir, Turkey. taylanally@yahoo.com
- Publication Type:Original Article
- Keywords:
Familial Mediterranean Fever;
S100A12;
Chitotriosidase;
Resolvin D1;
Serum Amiloid A
- MeSH:
Adult;
Biomarkers;
Docosahexaenoic Acids/*blood;
Familial Mediterranean Fever/*blood/*diagnosis;
Feasibility Studies;
Female;
Hexosaminidases/*blood;
Humans;
Male;
Reproducibility of Results;
S100A12 Protein/*blood;
Sensitivity and Specificity
- From:Journal of Korean Medical Science
2015;30(9):1241-1245
- CountryRepublic of Korea
- Language:English
-
Abstract:
Familial Mediterranean fever (FMF) is an auto-inflammatory disease characterised by periodic inflammatory attacks. We investigated changes in monocyte-granulocyte derived S10012A and chitotriosidase in both the attack and silent period of FMF for better estimation of inflammation. Endogenous resolvin was determined for utility to restrict inflammation. This study included 29 FMF patients (15 M/14 F) and 30 healthy controls (15 M/15 F). Serum levels of highly sensitive C-reactive protein, serum amiloid A (SAA), S100A12, chitotriosidase, and resolvin D1 were measured. Age, sex, body mass indexes, and lipids were similar between patients and controls. Biomarkers including hs-CRP, SAA, S100A12, chitotriosidase, and resolvin D1 were higher in the attack period of FMF patients compared to controls (P < 0.001). When FMF patients in the silent period were compared with their attack period, hs-CRP, SAA, and chitotriosidase were found elevated in the attack period (P < 0.001, P < 0.001, and P = 0.02 respectively). Serum levels of SAA, S100A12, chitotriosidase, and resolvin D1 in the silent period of FMF patients were still found elevated compared to healthy controls, indicating subclinical inflammation (P < 0.001, P < 0.001, P = 0.009, and P < 0.001 respectively ). In subgroup analysis, patients with M694V homozygote and heterozygote mutations had higher S10012A and hs-CRP compared to other mutation carriers. Our findings indicate that chitotriosidase and S10012A are useful in diagnosis and detection of subclinical inflammation and/or assessment of disease activity in FMF patients. They could be more informative for inflammation in various disease states compared to hsCRP and SAA. Resolvin D1 is elevated in both the attack and silent periods of FMF. It may be helpful to restrict inflammation.
